The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The mutational landscape of older patients with IDH wild-type glioblastoma (GBM).
 
Margaret O Johnson
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
 
Michael J. Glantz
Consulting or Advisory Role - Biocept
Research Funding - Abbvie (Inst); Cell Therapeutics (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Newlink Genetics (Inst); Orbus Therapeutics (Inst); RTOG (Inst); Sunovion (Inst); Tocagen (Inst); Triphase Accelerator Corp (Inst); Vascular Biogenics (Inst)
 
Jia Zeng
Employment - Caris Life Sciences
 
Clark C Chen
Consulting or Advisory Role - Clearpoint; GTMedical; Medtronic
 
Erin M. Dunbar
No Relationships to Disclose
 
Ekokobe Fonkem
No Relationships to Disclose
 
Santosh Kesari
No Relationships to Disclose
 
Andrew J. Brenner
Leadership - NanoTX
Stock and Other Ownership Interests - NanoTX; Plus Therapeutics
Honoraria - Vascular Biogenics
Consulting or Advisory Role - Alamab Therapeutics; NanoTX; Plus Therapeutics; Vascular Biogenics
Research Funding - Boston Biomedical (Inst); Immunomedics (Inst); Medicenna (Inst); miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Upsher-Smith (Inst); Vascular Biogenics
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Herbert B. Newton
No Relationships to Disclose
 
Justin Low
No Relationships to Disclose
 
Ashley Love Sumrall
Stock and Other Ownership Interests - Novocure (I)
Honoraria - Cardinal Health; Gerson Lehrman Group
Consulting or Advisory Role - Abbvie; Amgen; Athenex; Bayer; Merck; Novocure
Speakers' Bureau - Abbvie; Bayer; Bristol-Myers Squibb; Novocure; Prime Oncology
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Kura Oncology (Inst); Novocure (Inst); Oncoceutics (Inst)
Travel, Accommodations, Expenses - American Association of Neurological Surgeons; Bristol-Myers Squibb; Novocure; Xcenda
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
David M. Ashley
Stock and Other Ownership Interests - Diverse Biotech
Consulting or Advisory Role - Istari Oncology, Inc.; Jackson Laboratory for Genomic Medicine
Patents, Royalties, Other Intellectual Property - Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/787,508 filed January 2, 2019 Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/620,577 filed January 23, 2018
Expert Testimony - Tanoury, Nauts, McKinney & Garbarino, PLLC